Articles related to OFF-LABEL USE

Ozempic, commonly used off-label for weight management, can cause significant facial side effects, termed “Ozempic face,” marked by increased wrinkling and loss of skin elasticity.

This study underscores the potential of IV ketamine in managing major depressive disorder, especially in patients with a history of multiple antidepressant trials. With a significant percentage achieving response or remission within six weeks, and these benefits sustained over months, ketamine offers a promising avenue for chronic depression management.

Despite the potential benefits of ketamine in treating a range of neurological and psychiatric disorders, the FDA has issued warnings about the potential risks associated with its use, emphasizing the need for careful prescription and clinical oversight.

As we navigate this new era of oncology care, it’s important to remember that only 38% of studies combining chemotherapy with a targeted treatment administered both drugs at full dose. This underscores the need for careful dose adjustments when combining different classes of drugs.

The recent study on topiramate’s potential role in PTSD treatment has shown that three times as many patients taking topiramate saw their PTSD symptoms decrease below the clinical threshold compared to those on placebo.

This observational study compared IV ketamine (47) to IN esketamine (15) in 62 adults suffering treatment-resistant depression. Response was measured using the QIDS-SR tool. The results? The two formulations were comparable in terms of change between baseline and endpoint QIDS-SR and response rates. However, IV ketamine generated benefits with fewer treatments.